CVS Caremark Corp.'s second-quarter earnings jumped 16 percent, as the drugstore operator and pharmacy benefits manager continued to reap bottom-line gains from generic drugs.
The Woonsocket, R.I., company also said Tuesday that it had narrowed its 2013 earnings forecast in part to account for share repurchases.
CVS Caremark earned $1.12 billion, or 91 cents per share, in the three months that ended June 30, up from $966 million, or 75 cents per share, a year earlier.
Adjusted earnings totaled 97 cents per share.
Copyright 2013 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.